Potential cardioprotective actions of no-releasing aspirin
Author:
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.nature.com/articles/nrd794.pdf
Reference105 articles.
1. Vane, J. R. The fight against rheumatism: from willow bark to COX-1 sparing drugs. J. Physiol. Pharmacol. 51, 573–586 (2000).
2. Patrono, C. Aspirin as an antiplatelet drug. N. Engl. J. Med. 330, 1287–1294 (1994).A comprehensive review of the rationale behind the use of aspirin to prevent cardiovascular disease, and its mechanisms of action.
3. Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N. Engl. J. Med. 321, 129–135 (1989).
4. The RISC Group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 336, 827–830 (1990).
5. The SALT Collaborative Group. Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 338, 1345–1349 (1991).
Cited by 132 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Low dose aspirin prevents endothelial dysfunction in the aorta and foetal loss in pregnant mice infected with influenza A virus;Frontiers in Immunology;2024-04-04
2. Microwave-induced synthesis as a part of green chemistry approach for novel antiinflammatory agents;Green Approaches in Medicinal Chemistry for Sustainable Drug Design;2024
3. Potentially active aspirin derivative to release nitric oxide: In-vitro, In-vivo and in-silico approaches;Saudi Pharmaceutical Journal;2023-12
4. The anti-inflammatory and vasoprotective properties of mPGES-1 inhibition offer promising therapeutic potential;Expert Opinion on Therapeutic Targets;2023-11-02
5. Ursolic Acid Derivatives Down Regulate Inflammatory Mediators;Journal of the Brazilian Chemical Society;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3